Medical devices, healthcare technology and the business of care
PMA approval · P220003

PASCAL Precision Transcatheter Valve Repair System

Edwards Lifesciences, LLC · Decision date Sep 14, 2022

MEDTECHLEDGER EXPLANATIONP220003

What did the FDA approve?

The FDA database entry for P220003 records an approval decision dated September 14, 2022 for the PASCAL Precision Transcatheter Valve Repair System from Edwards Lifesciences, LLC. The decision field is APPR, and the product code is NKM under the cardiovascular specialty.

The statement describes the device as indicated for percutaneous reduction of significant, symptomatic mitral regurgitation (MR >= 3+) due to primary abnormality of the mitral apparatus, described as degenerative MR, in patients determined by a heart team to be at prohibitive risk for mitral valve surgery. The heart team includes a cardiac surgeon experienced in mitral valve surgery and a cardiologist experienced in mitral valve disease, and existing comorbidities must not preclude the expected benefit from reduction of the MR. The entry does not state whether this decision is an original PMA or a supplement, and no supplement type or reason is supplied.

FDA approval order statement

Approval for the PASCAL Precision Transcatheter Valve Repair System. This device is indicated for the percutaneous reduction of significant, symptomatic mitral regurgitation (MR >= 3+) due to primary abnormality of the mitral apparatus (degenerative MR) in patients who have been determined to be at prohibitive risk for mitral valve surgery by a heart team, which includes a cardiac surgeon experienced in mitral valve surgery and a cardiologist experienced in mitral valve disease, and in whom existing comorbidities would not preclude the expected benefit from reduction of the MR.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Sep 14, 2022

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P220003
Regulatory pathway
Premarket approval application
Product code
NKM
Decision code
APPR
Decision date
Sep 14, 2022
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Mitral valve repair devices.

Product code
NKM
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P220003 received

    Application receipt date recorded by FDA.

  2. P220003 · FDA decision

    APPR

  3. P220003/S033 · Related supplement

    PASCAL Precision Transcatheter Valve Repair System

  4. P220003/S028 · Related supplement

    PASCAL Ace with Capture Clarity Valve Repair System MR Implant System

  5. P220003/S029 · Related supplement

    PASCAL Precision Transcatheter Valve Repair System

  6. P220003/S032 · Related supplement

    PASCAL Precision Transcatheter Valve Repair System

Timeline entries are records held by MedtechLedger for P220003. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P220003

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Edwards Lifesciences, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
One Edwards Way, Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records